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Abstract
Background: Selecting an interbody cage with appropriate height is one of the key steps in lumbar interbody
fusion, and has an important impact on clinical efficacy. How to choose the appropriate height of the cage
becomes one of the core problems of lumbar interbody fusion for spine surgeons. However, studies about
objective selection criteria on interbody cage height was rare.
Methods: One hundred fifty-seven patients with single segment lumbar degenerative diseases treated by TLIF
surgery from January 2011 to July 2013 were retrospectively analyzed. Parameters analyzed included: gender,
age, body height, clinical diagnosis, pathological segment location and the intervertebral height of pathological
segment, pathological segment activity, the intervertebral height of the adjacent segments. And further to analyze
the correlation between these parameters and interbody cage height. By measuring the intervertebral height of
pathological segment and normal segment to calculate the regression equation of interbody cage height.
Results: The average interbody cage height of male patients (12.38 ± 1.43) mm was significantly higher than female
(11.62 ± 1.45) mm (p < 0.001). The L4-5 segment interbody cage height (12.11 ± 1.38) mm was significantly greater
than the L5-S1 (11.25 ± 1.32) mm (p = 0.04). Body height, the intervertebral height of pathological segment, and
the middle intervertebral heigh of upper adjacent segment were highly positively correlated to the interbody
cage height. The range of interbody cage height used in transforaminal lumbar interbody fusion for Chinese
patients with lumbar degenerative diseases was: L3-4 (11.28 ± 3.29) mm ~ (12.76 ± 2.40) mm, L4-5 (11.62 ± 2.89)
mm ~ (13.18 ± 1.91) mm, L5-S1 (10.52 ± 2.22) mm ~ (11.90 ± 2.80) mm. The regression equation of interbody
cage height was: interbody cage height = 11.123-0.563 * (gender) + 0.149 * (the middle intervertebral height of
pathological segment).
Conclusions: The selection of interbody cage height was influenced by sex, body height, pathological segment
location, the intervertebral height of pathological segment and other factors. The interbody cage height for the
lower lumbar spine mostly selected 11,12,13 mm, L3-4, L4-5 segment highly selective in general should not be
less than 10 mm, and L5-S1 segments height was relatively small, usually not more than 13 mm. The interbody
cage height might be selected based on the regression equation of interbody cage height. But, the regression
equation maybe need to be verified in a prospective study.
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Background
Lumbar fusion has been proved excellent clinical effect
after more than 100-year development since Albee FH
[1] and Hibbs RA [2] first used in 1911, and has become
one of the most commonly used operative methods for
treating lumbar degenerative diseases which includes
posterolateral fusion and interbody fusions [3–5]. The
reconstruction of the sagittal balance has become the
important purpose of lumbar fusion surgery [6]. Com-
pared with posterolateral fusion, lumbar interbody fu-
sion could restore the supporting role of the anterior
column and intervertebral disc height effectively, and
provide immediate postoperative stability, which lead to
a gradual increase in the proportion of clinical applica-
tion in recent years [7–10].
Transforaminal lumbar interbody fusion (TLIF) has been
widely performed in recent years [11–17], and could effect-
ively restore the intervertebral height, correct lordosis in
the pathological lumbar segment and achieve a satisfactory
prognosis [8, 9, 18, 19]. The lumbar fusion cage, which has
been generally accepted, is an alternative method to autolo-
gous bone graft, and is mainly used to fill the gap in height
after the discectomy and the removal of the superior and
inferior cartilage endplates in the diseased segment. Mean-
while, the lordosis in the diseased segment is corrected
through the strong fixation using the screw-rod system in
the maintenance of base height via the fusion cage. Hsieh
PC et al. [6] reported that the local disc angle became
smaller after TLIF, which was considered to be caused by
an inappropriate posterior position of the implanted fusion
cage. This result indicated that the height and position of
the implanted fusion cage pathological the recovery from
lumbar lordosis and the postoperative prognosis.
Selecting an interbody cage with appropriate height is
one of the key steps in lumbar interbody fusion, and has
an important impact on clinical efficacy. An oversized
cage will not only lead to over distraction of interverte-
bral space, which may increase abnormal stress in the
adjacent segments resulting in increasing the incidence
of degeneration of the adjacent segments, but will in-
crease the chance to injury the nerve roots. Using a fu-
sion cage too low in height, on the other hand, will fail
to restore the intervertebral height and lordosis, and
may lead to severe complications such as cage migration
and fusion failure [20, 21]. Thus, how to choose the ap-
propriate height of the cage becomes one of the core
problems of lumbar interbody fusion for spine surgeons.
But the interbody cage height in TLIF has long been de-
termined by surgeons mostly based on their operational
experience. Hence, it is meaningful to investigate the re-
lated factors in the selection of interbody cage height.
The present study attempt to compare the differences
in the height of fusion cages used for different disease
types or different affected segments based on body
height, age, diagnosis, pathological segment location and
imaging data collected from patients treated with TLIF.
The aim of this study was to measure the intervertebral
disc height of normal and pathological segments affected
by degenerative diseases, to investigate the factors related
to the selection of fusion cage height and to provide refer-
ence for height selection of cages in TLIF for patients with
lumbar degenerative diseases. This study was conducted
with approval from the Ethics Committee of Huashan
Hospital, Fudan University. Written informed consent was
obtained from all participants before the operation.
Methods
Patient selection
We retrospectively analyzed 157 consecutive patients who
underwent TLIF for one-segment lumbar degenerative
diseases between January 2011 and July 2013 based on fol-
lowing inclusion criteria: 1). The patients were diagnosed
as lumbar degenerative diseases (lumbar disc herniation,
lumbar spinal stenosis or lumbar degenerative spondylo-
listhesis) in L3-4, L4-5 or L5-S1; 2). The patients underwent
single-level TLIF with one interbody cage implanted; 3).
During the follow-up, there were no complications such as
fusion failure, cage retropulsion or pseudarthrosis forma-
tion in at least 6 months; 4). The upper and lower adjacent
lumbar intervertebral discs were Pfirrmann grade ≤ III
[22]. This study was conducted with approval from the
Ethics Committee of Huashan Hospital, Fudan University.
Written informed consent was obtained from all patients.
The exclusion criteria were as follows: 1). The patients
were diagnosed as isthmic spondylolisthesis, lumbar
scoliosis, multiple lumbar degenerative diseases, lumbar
secondary surgery, one-segment lumbar degenerative
diseases in L1-2, L2-3, or one-segment lumbar degenera-
tive diseases with lumbar fractures, severe osteoporosis,
spinal canal tumor or other space-occupying lesions. 2).
The patients who had two cages implanted. 3). The pa-
tients lost of follow-up, or less than 6 months, or had
complications such as fusion failure, cage retropulsion
or pseudarthrosis formation. 4). There were adjacent
lumbar intervertebral discs observed between Pfirrmann
Grade IV and Grade V [22].
In the selected patients, there were 68 male patients and
89 female patients, with an average age of 58.0 ± 12.5 years
and an average body height of 163.5 ± 8.5 cm. There were
64 patients with lumbar disc herniation, 51 patients with
lumbar spinal stenosis and 42 patients with spondylolisth-
esis. The surgical procedures were performed on L3–4 in
9 patients, L4–5 in 125 patients and L5–S1 in 23 patients
(Table 1).
Study design
All enrolled subjects underwent lumbar anteroposterior,
lateral and dynamic radiographs. All imaging parameters
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on the X-ray radiographs were measured by two experi-
enced radiologists using the Centricity Enterprise Web
v3.0 (General Electric Com., New York). The following
specific measurement parameters were included. 1). The
measurement of the intervertebral height taken from the
lateral position: One straight line was extended tangent
to the inferior endplate of the pathological segment.
Three lines were then extended from the anterior, pos-
terior edge and midpoint of the superior endplate verti-
cally toward the line from the inferior endplate, and the
length of these vertical line segments were defined as
the anterior, posterior intervertebral height (AIVH &
PIVH) and the intervertebral height at the midpoint of
the pathological segment (MIVH). The same method as
described above was used to measure the intervertebral
height at the midpoint of the superior and inferior seg-
ment, short for s-MIVH and i-MIVH, respectively
(Fig. 1a). 2). The range of motion (ROM) of the patho-
logical segment was measured as the difference between
the two angles from the radiographs taken at the anter-
ior flexion and posterior extension positions based on
the Cobb method (Fig. 1b and c).
Surgical management
The same group experienced spine surgeons performed
all TLIF surgeries operated on each patient using bilat-
eral internal fixation [23]. With adequate intraoperative
decompression, a Capstone lumbar interbody fusion
cage (Medtronic Sofamor Danek USA Inc., Memphis,
Tennessee) was implanted after distraction. The selec-
tion criteria of interbody cage height for this group pa-
tients as followed: 1) The intervertebral segment had
good stability with certain pull-out resistance after
implanting the interbody cage. 2) The height and lordo-
sis of operational segment got a good recovery con-
firmed by intraoperative fluoroscopy. 3) Both the upper
and lower bony endplates of operational segment were
kept intact,and the lower nerve root was no significant
longitudinal traction. Bone fusion in the pathological
segment was detected in postoperative follow-up.
Among the enrolled subjects, 2 cages at 8 mm, 36 cages
at 10 mm, 83 cages at 12 mm and 36 cages at 14 mm
were implanted.
Data analysis
SPSS 19.0 statistical software (SPSS Inc., Chicago, Illinois)
was used for the statistical analysis. The difference was
statistically significant if p < 0.05. Kruskal-Wallis H test
was used to compare the differences between the diseases,
Wilcoxon test was used to compare the differences be-
tween different segments, t test was used to compare the
differences between MIVH, s-MIVH and s-MIVH, and
genders. Associations between the radiological parameters
Table 1 The basic data of 157 patients with one-segment lumbar degenerative diseases
Disc level Disease type Male Female Average age (y) Average height (cm) LDH LSS DLS
L3-4 9 3 6 60.4 ± 10.1 164.1 ± 9.4 3 3 3
L4-5 125 54 71 59.9 ± 11.8 163.0 ± 7.9 48 45 32
L5-S1 23 11 12 48.7 ± 13.3 166.4 ± 7.9 23 3 7
Total 157 68 89 58.0 ± 12.5 163.5 ± 8.5 64 51 42
LDH: lumbar disc herniation, LSS: lumbar spinal stenosis, DLS: degenerative lumbar spondylolisthesis
Fig. 1 Measurement methods of the intervertebral height and range of motion. a Measurement methods of the anterior, posterior intervertebral
height (AIVH & PIVH) and the intervertebral height at the midpoint of the pathological segment (MIVH), and the intervertebral height at the
midpoint of the superior and inferior segment (s-MIVH and i-MIVH, respectively). b and c The range of motion (ROM) of the pathological segment
is measured based on the Cobb method, and is the difference between Angle α andβ
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and the interbody cage height were analyzed with
Spearman correlation analysis.
Results
Differences in the fusion cages used for different disease
types
The Kruskal-Wallis H Test showed no differences in the
height of the fusion cages used for different disease types
(p = 0.20). For each disease type, no significant difference
was observed in pairwise inter-group comparison (8 mm
fusion cages were not included in the analysis due to the
small sample size). The average fusion cage height used
was 12.16 ± 1.30 mm in the lumbar disc herniation
group, 12.00 ± 1.55 mm in the lumbar spinal stenosis
group and 11.57 ± 1.43 mm in the lumbar degeneration
spondylolisthesis group.
Differences in fusion cage usage for different segments
Due to the small size of the L3–4 group and the 8 mm
fusion cage group, fusion cage usage was only compared
between the L4–5 group and the L5–S1 group using the
Wilcoxon rank sum test. A p value of 0.04 was obtained,
indicating that the average height of the fusion cages used
for diseased L4–5 segment (12.11 ± 1.38 mm) was greater
than that for the L5–S1 segment (11.25 ± 1.32 mm).
Differences in fusion cages used between different
genders
Significant differences were observed in the average
height of the fusion cages used between male and female
subjects (p < 0.001; the 8 mm fusion cage was not in-
cluded). The average height of the fusion cages used in
male subjects (12.38 ± 1.43 mm) was greater than that
used in female subjects (11.62 ± 1.45 mm). (Table 2)
Correlation between fusion cage height and index
parameters
A Spearman correlation analysis was performed between
the fusion cage height and age, body height, AIVH,
MIVH, PIVH, i-MIVH, s-MIVH and ROM of the patho-
logical segment. The fusion cage height showed positive
correlations with AIVH, MIVH, PIVH, s-MIVH and
body height, with the correlation coefficients in ascend-
ing order. With increases in these parameters, the height
of the fusion cage increased correspondingly (Table 3).
Intervertebral disc height of normal and pathological
segments
In the present study, the intervertebral height of 291
segments assessed between Pfirrmann Grade I to Grade
III were measured. According to Pfirrmann classification
of disc degeneration, the intervertebral disc height of
Grade I to Grade III indicate no height loss or slightly
decrease [22]. So the adjacent segments could be con-
sidered as normal or similar to normal intervertebral
disc height. The average MIVH of L2-3 to L5-S1 was
12.15 ± 2.42 mm, 12.76 ± 2.40 mm, 13.18 ± 1.91 mm,
11.90 ± 2.80 mm, respectively (Table 4).
Stepwise regression of fusion cage height
Stepwise regression equations were obtained using the fu-
sion cage height as the dependent variable and the above
parameters as the independent variables, which showed
significant differences. These variables included gender
(male = 1, female = 2), AIVH, MIVH, PIVH, s-MIVH and
body height. The stepwise regression equation was sig-
nificant (p < 0.001) with the retained two independent
variables, gender and MIVH. The equation was as fol-
lows: interbody cage height = 11.123 – 0.563*gender +
0.149*MIVH.
Discussion
Unlike the prone position the subjects assumed in the
fusion surgery, the basic function of the human spine is
load-bearing, and thus, the height and curvature formed
with the fusion cage implanted in a non-load-bearing
state are likely to deviate from those under the normal
upright position. Literature [24] reports indicated that
the normal human lumbar exhibited significantly in-
creased local disc angle in the L2–3 and L3–4 segments
and markedly reduced local disc angle in the L5–S1 seg-
ment in response to axial stress. This result suggested
Table 2 Statistical data of the selection of fusion cage height with different diagnosis, segments and gender
Fusion cage height 8 mm 10 mm 12 mm 14 mm Average height (mm) p
LDH 0 11 37 16 12.16 ± 1.30 0.20
LSS 1 12 24 14 12.00 ± 1.55
DLS 1 13 22 6 11.57 ± 1.43
L3-4 0 3 2 4 12.22 ± 1.86 0.04
L4-5 1 24 69 31 12.11 ± 1.38
L5-S1 1 9 12 1 11.25 ± 1.32
Male 2 6 37 23 12.38 ± 1.43 <0.001
Female 0 30 46 13 11.62 ± 1.45
LDH: lumbar disc herniation, LSS: lumbar spinal stenosis, DLS: degenerative lumbar spondylolisthesis
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that in response to axial stress, the upper lumbar
spine tends to disperse the force toward the medial
and posterior column, while the lower lumbar spine
compresses the intervertebral height to some extent.
The differences in the lumbar intervertebral height
are determined by the anatomical structure and the
physiological characteristics of the lumbar spine itself,
which is consistent with the finding from the present
study that the height of the fusion cage used in the
surgery correlated with the segment pathological by
the disease rather than with the disease type itself.
On the other hand, Videman T et al. [25] found that
the lower lumbar intervertebral height decreased with
age in an elderly sample. Meanwhile, large individual
variance in the height reduction was found in the
same study, which might explain why age was not
found to correlate with the height of the fusion cage
in the present study.
According to the results from this study, the MIVH
of the pathological segments from L3-4 to L5-S1 was
11.28 ± 3.29 mm, 11.62 ± 2.89 mm, 10.52 ± 2.22 mm,
which was significantly lower than those of the nor-
mal segments: 12.76 ± 2.40 mm, 13.18 ± 1.91 mm and
11.90 ± 2.80 mm, respectively. Therefore, the proper
cage height of Chinese population should be within
the range of the two sets of data mentioned above of
each segment. The average cage height of each segment
we actually used was 12.22 ± 1.86 mm, 12.11 ± 1.38 and
11.25 ± 1.32 mm, which, however, was exactly within
the proper range that proved the adequacy of the
choice of the cage height in this sample. Combined
with common cage scale, we recommend that the
cage height of L3-4 and L4-5 level via TLIF should
be 11, 12 or 13 mm, while for L5-S1 level, 10, 11 or
12 mm would be more appropriate, which means, in
Chinese population, the interbody cage height for
patients with lumbar degenerative diseases should
not be lower than 10 mm in L3-4 and L4-5 segment,
and not be greater than 13 mm in L5-S1 segment. In
addition, the stepwise regression equation: interbody cage
height = 11.123 – 0.563*gender + 0.149*MIVH, presented
in the study could be used to estimate the interbody cage
height preliminarily during the operation.
There were some limitations in this retrospective
study. The small sample size and the large deviation
of segmental distribution might have an impact on
the accuracy of some parameters, especially for L3-4
segment. The results of L3-4 segment need to be
more careful handling. Besides, the selection of the
size of the interbody cage for each patient in this
sample group was mainly depend on the surgeons’
experience during the operation, of which the correct-
ness should be proved in further studies, despite of
the height of the cages used was within the range of
the intervertebral height at the midpoint of the
pathological and normal segments.
Conclusion
In summary, the selection of interbody cage height
was influenced by gender, body height, pathological
segment location, the intervertebral height of patho-
logical segment and other factors. The interbody cage
height for the lower lumbar spine mostly selected was
11,12,13 mm, L3-4, L4-5 segment highly selective in
general should not be less than 10 mm, and L5-S1
segments height was relatively small, usually not more
than 13 mm. The interbody cage height might be
calculated before surgery for reference based on the
regression equation as follows: interbody cage height =
11.123 – 0.563*gender + 0.149*MIVH. But, the regression
equation maybe need to be verified in a prospective study.
Table 3 Correlation between fusion cage height and index parameters
Age Body height AIVH MIVH PIVH s-MIVH i-MIVH ROM
Coefficient of correlation - 0.169 0.331 0.331 0.314 0.183 - -
p 0.850 0.034 <0.001 <0.001 <0.001 0.022 0.143 0.187
AIVH: anterior posterior intervertebral height, MIVH: intervertebral height at the midpoint, PIVH: posterior intervertebral height, s-MIVH: intervertebral height at the
midpoint of the superior segment, i-MIVH: intervertebral height at the midpoint of the inferior segment, ROM: range of motion
Table 4 Intervertebral disc height of normal and pathological segment
Parameters Number of segments MIVH Height of
fusion cageSegments Pathological segments Normal segments Pathological segments Normal segments
L3-4 9 125 11.28 ± 3.29 12.76 ± 2.40 12.22 ± 1.86
L4-5 125 32 11.62 ± 2.89 13.18 ± 1.91 12.11 ± 1.38
L5-S1 23 125 10.52 ± 2.22 11.90 ± 2.80 11.25 ± 1.32
MIVH: intervertebral height at the midpoint
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